BIOTECH DRUGS, THE VALUE OF INNOVATION

被引:0
|
作者
Ja, Schoenenberger
机构
来源
ATENCION FARMACEUTICA | 2011年 / 13卷 / 04期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:195 / 196
页数:2
相关论文
共 50 条
  • [31] Biotech drugs - Regulatory and technological issues
    Caglioti, L
    [J]. CHIMICA OGGI-CHEMISTRY TODAY, 2003, 21 (10-11) : 24 - 24
  • [32] Fake biotech drugs raise concerns
    Jeffrey L. Fox
    [J]. Nature Biotechnology, 2001, 19 : 603 - 603
  • [33] DELIVERY BECOMING KEY FOR BIOTECH DRUGS
    KLAUSNER, A
    [J]. BIO-TECHNOLOGY, 1986, 4 (09): : 755 - 756
  • [34] FDA TO EASE REGULATION OF BIOTECH DRUGS
    BARNETT, AA
    [J]. LANCET, 1995, 346 (8986): : 1357 - 1357
  • [35] New market potential for biotech drugs
    Wechsler, J
    [J]. BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1997, 10 (10): : 20 - 22
  • [36] BECHTEL TARGETS FOOD, DRUGS AND BIOTECH
    SUSCA, P
    [J]. GENETIC ENGINEERING NEWS, 1991, 11 (03): : 1 - +
  • [37] Prices, profits, and innovation: Examining criticisms of new psychotropic drugs' value
    Huskamp, Haiden A.
    [J]. HEALTH AFFAIRS, 2006, 25 (03) : 635 - 646
  • [38] Innovation in breakthrough drugs and vaccines: Development risk, patient impact, and value
    Prigodich, Andrew E.
    Wang, Shuntai
    Verhoest, Patrick
    Warne, Nicholas
    Allerton, Charlotte
    Burkhardt, John
    Fernando, Kathy
    Dolsten, Mikael
    [J]. DRUG DISCOVERY TODAY, 2021, 26 (10) : 2232 - 2237
  • [39] Fake biotech drugs raise concerns
    Fox, JL
    [J]. NATURE BIOTECHNOLOGY, 2001, 19 (07) : 603 - 603
  • [40] NO MORE SPECIAL SAFEGUARDS FOR BIOTECH DRUGS
    KLEINER, K
    [J]. NEW SCIENTIST, 1995, 148 (2004) : 12 - 12